FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway

Abstract

BackgroundNasopharyngeal carcinoma (NPC) is well-known for its highly metastatic characteristics, but little is known of its molecular mechanisms. New biomarkers that predict clinical outcome, in particular the ability of the primary tumor to develop metastatic tumors are urgently needed. The aim of this study is to investigate the role of FLJ10540 in human NPC development.MethodsA bioinformatics approach was used to explore the potentially important regulatory genes involved in the growth/metastasis control of NPC. FLJ10540 was chosen for this study. Two co-expression strategies from NPC microarray were employed to identify the relationship between FLJ10540 and osteopontin. Quantitative-RT-PCR, immunoblotting, and immunohistochemistry analysis were used to investigate the mRNA and protein expression profiles of FLJ10540 and osteopontin in the normal and NPC tissues to confirm microarray results. TW01 and Hone1 NPC cells with overexpression FLJ10540 or siRNA to repress endogenous FLJ10540 were generated by stable transfection to further elucidate the molecular mechanisms of FLJ10540-elicited cell growth and metastasis under osteopontin stimulation.ResultsWe found that osteopontin expression exhibited a positive correlation with FLJ10540 in NPC microarray. We also demonstrated comprehensively that FLJ10540 and osteopontin were not only overexpressed in NPC specimens, but also significantly correlated with advanced tumor and lymph node-metastasis stages, and had a poor 5-year survival rate, respectively. Stimulation of NPC parental cells with osteopontin results in an increase in FLJ10540 mRNA and protein expressions. Functionally, FLJ10540 transfectant alone, or stimulated with osteopontin, exhibited fast growth and increased metastasis as compared to vehicle control with or without osteopontin stimulation. Conversely, knockdown of FLJ10540 by siRNA results in the suppression of NPC cell growth and motility. Treatment with anti-CD44 antibodies in NPC parental cells not only resulted in a decrease of FLJ10540 protein, but also affected the abilities of FLJ10540-elicited cell growth and motility in osteopontin stimulated-NPC cells.ConclusionsThese findings suggest that FLJ10540 may be critical regulator of disease progression in NPC, and the underlying mechanism may involve in the osteopontin/CD44 pathway.

Upregulation of CEP55 Predicts Dismal Prognosis in Patients with Liver Cancer

“…The higher the expression of CEP55 was, the poorer the differentiation of tumor cells. Similar results were found in prostate cancer and nasopharyngeal carcinoma [27,28]. These findings clearly suggest the significance of CEP55 in tumorigenesis.…”

Prognostic and Predictive Values of cell Cycle Proteins Centrosomal Protein 5 (CEPP 5)

“…Suchabnormalitiesarecommoncriteria in malignant EOC cells [14]. Also, CEP55 overexpression promoted growth signaling pathways that could result in cancer cell metastasis and poor patient prognosis [16]. All these findings have suggested that CEP55 played a major role in cancer initiation and progression, which explain our results about association between CEPP55 overexpression, tumor aggressiveness, worse clinicopathological and prognostic parameters Similar to our findings CEP55 protein overexpression had been found to be related to tumor aggressiveness in a plethora of cancers [17,18].…”

Suppression of CEP55 reduces cell viability and induces apoptosis in human lung cancer

“…In the present study, the in vitro studies demonstrated that CEP55 knockdown inhibited cell viability and proliferation through the induction of cell cycle arrest and apoptosis in the NSCLC cell lines A549 and 95D, indicating antitumor activity of CEP55 inhibition. Evidence points to the contribution of CEP55 in cell proliferation involved in gastric (9) and breast (10) cancers, as well as nasopharyngeal carcinomas (15). To the best of our knowledge, dysregulation of cell proliferation is the key characteristic of cancer cells, which is closely associated with cell cycle regulation (16,17).…”